Logiscreen

Resmed Inc

$196.04
Market Cap 28.56B
ROE 24.4%
Gross Margin 62.2%
Debt/Equity 0.1
Current Ratio 3.0
Revenue QoQ 10.8%
EPS QoQ 0.1%
F-Score 6

About

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.

Exchange
NYSE
Sector
Healthcare
Industry
Medical Instruments & Supplies

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
18.63
vs median 31.50
P/B
4.36
vs median 2.17
ROE
0.24
vs median 0.09

Decent quality with acceptable fundamentals

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics